These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 32925909)
1. Impact of a pay-for-performance scheme for long-acting reversible contraceptive (LARC) advice on contraceptive uptake and abortion in British primary care: An interrupted time series study. Ma R; Cecil E; Bottle A; French R; Saxena S PLoS Med; 2020 Sep; 17(9):e1003333. PubMed ID: 32925909 [TBL] [Abstract][Full Text] [Related]
2. Cost-benefit analysis of enhancing the uptake of long-acting reversible contraception in Australia. Concepcion K; Lacey S; McGeechan K; Estoesta J; Bateson D; Botfield J Aust Health Rev; 2020 Jun; 44(3):385-391. PubMed ID: 31655632 [TBL] [Abstract][Full Text] [Related]
3. Predictors of choosing long-acting reversible contraceptive methods when provided free-of-charge - A prospective cohort study in Finland. Gyllenberg F; Saloranta T; But A; Gissler M; Heikinheimo O Contraception; 2020 Jun; 101(6):370-375. PubMed ID: 32061566 [TBL] [Abstract][Full Text] [Related]
4. Factors that influence the choice of long-acting reversible contraceptive use among adolescents post-abortion in Chongqing, China: a cross-sectional study. Jin F; Yang Y; Sun J; Li R; Yao F; Liu X J Obstet Gynaecol; 2024 Dec; 44(1):2316625. PubMed ID: 38353518 [TBL] [Abstract][Full Text] [Related]
5. Impact of pay for performance on prescribing of long-acting reversible contraception in primary care: an interrupted time series study. Arrowsmith ME; Majeed A; Lee JT; Saxena S PLoS One; 2014; 9(4):e92205. PubMed ID: 24694949 [TBL] [Abstract][Full Text] [Related]
6. Time trends in contraceptive prescribing in UK primary care 2000-2018: a repeated cross-sectional study. Pasvol TJ; Macgregor EA; Rait G; Horsfall L BMJ Sex Reprod Health; 2022 Jul; 48(3):193-198. PubMed ID: 34782337 [TBL] [Abstract][Full Text] [Related]
7. Risk factors and the choice of long-acting reversible contraception following medical abortion: effect on subsequent induced abortion and unwanted pregnancy. Korjamo R; Heikinheimo O; Mentula M Eur J Contracept Reprod Health Care; 2018 Apr; 23(2):89-96. PubMed ID: 29537321 [TBL] [Abstract][Full Text] [Related]
8. Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers. Luo Z; Gao L; Anguzu R; Zhao J Reprod Health; 2018 May; 15(1):85. PubMed ID: 29793501 [TBL] [Abstract][Full Text] [Related]
9. Comparison of unintended pregnancy at 12 months between two contraceptive care programs; a controlled time-trend design. Madden T; Paul R; Maddipati R; Buckel C; Goodman M; Peipert JF Contraception; 2019 Sep; 100(3):196-201. PubMed ID: 31132346 [TBL] [Abstract][Full Text] [Related]
10. Association Between Women's Use of Long-Acting Reversible Contraception and Declining Abortion Rates in New Zealand. Whitley CE; Rose SB; Sim D; Cook H J Womens Health (Larchmt); 2020 Jan; 29(1):21-28. PubMed ID: 31600111 [No Abstract] [Full Text] [Related]
11. The Impact of Balanced Counseling on Contraceptive Method Choice and Determinants of Long Acting and Reversible Contraceptive Continuation in Nepal. Sapkota S; Rajbhandary R; Lohani S Matern Child Health J; 2017 Sep; 21(9):1713-1723. PubMed ID: 26955996 [TBL] [Abstract][Full Text] [Related]
12. Effect of staff training and cost support on provision of long-acting reversible contraception in community health centers. Buckel C; Maddipati R; Goodman M; Peipert JF; Madden T Contraception; 2019 Apr; 99(4):222-227. PubMed ID: 30685287 [TBL] [Abstract][Full Text] [Related]
13. Factors predicting uptake of long-acting reversible methods of contraception among women presenting for abortion. Goldstone P; Mehta YH; McGeechan K; Francis K; Black KI Med J Aust; 2014 Oct; 201(7):412-6. PubMed ID: 25296065 [TBL] [Abstract][Full Text] [Related]
15. Induced Abortion in a Population Entitled to Free-of-Charge Long-Acting Reversible Contraception. Gyllenberg FK; Saloranta TH; But A; Gissler M; Heikinheimo O Obstet Gynecol; 2018 Dec; 132(6):1453-1460. PubMed ID: 30399102 [TBL] [Abstract][Full Text] [Related]
16. Increasing uptake of long-acting reversible contraception with structured contraceptive counselling: cluster randomised controlled trial (the LOWE trial). Emtell Iwarsson K; Envall N; Bizjak I; Bring J; Kopp Kallner H; Gemzell-Danielsson K BJOG; 2021 Aug; 128(9):1546-1554. PubMed ID: 33988917 [TBL] [Abstract][Full Text] [Related]
17. Attitudes toward long-acting reversible contraception among young women seeking abortion. Rose SB; Cooper AJ; Baker NK; Lawton B J Womens Health (Larchmt); 2011 Nov; 20(11):1729-35. PubMed ID: 21923281 [TBL] [Abstract][Full Text] [Related]
18. Quality of life of women using the etonogestrel long-acting reversible contraceptive implant after abortion for unplanned pregnancy. Caruso S; Vitale SG; Fava V; Pasqua SD; Rapisarda AMC; Cianci S Eur J Contracept Reprod Health Care; 2020 Aug; 25(4):251-258. PubMed ID: 32436733 [TBL] [Abstract][Full Text] [Related]
19. Factors Associated with New Uptake of Long-Acting Reversible Contraceptives Since the Affordable Care Act Among Privately Insured Women in Pennsylvania. Nelson HN; Thayer E; Bailey C; Leuenberger L; Lehman E; Chuang CH Womens Health Issues; 2019; 29(5):370-375. PubMed ID: 31337530 [TBL] [Abstract][Full Text] [Related]